[HTML][HTML] NF-κB: blending metabolism, immunity, and inflammation
D Capece, D Verzella, I Flati, P Arboretto, J Cornice… - Trends in …, 2022 - cell.com
The procurement and management of nutrients and ability to fight infections are fundamental
requirements for survival. These defense responses are bioenergetically costly, requiring …
requirements for survival. These defense responses are bioenergetically costly, requiring …
Recent advances in the treatment of insulin resistance targeting molecular and metabolic pathways: fighting a losing battle?
M Wolosowicz, S Prokopiuk, TW Kaminski - Medicina, 2022 - mdpi.com
Diabetes Mellitus (DM) is amongst the most notable causes of years of life lost worldwide
and its prevalence increases perpetually. The disease is characterized as multisystemic …
and its prevalence increases perpetually. The disease is characterized as multisystemic …
[HTML][HTML] Paternal phthalate exposure-elicited offspring metabolic disorders are associated with altered sperm small RNAs in mice
Exposure to ubiquitous plastic-associated endocrine disrupting chemicals (EDCs) is
associated with the increased risk of many chronic diseases. For example, phthalate …
associated with the increased risk of many chronic diseases. For example, phthalate …
Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses
Z Huang, S Shen, X Han, W Li, W Luo, L Lin… - EMBO molecular …, 2023 - embopress.org
Atherosclerosis is a chronic inflammatory disease with high morbidity and mortality rates
worldwide. Doublecortin‐like kinase 1 (DCLK1), a microtubule‐associated protein kinase, is …
worldwide. Doublecortin‐like kinase 1 (DCLK1), a microtubule‐associated protein kinase, is …
Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ
J Gan, L Guo, X Zhang, Q Yu, Q Yang, Y Zhang… - Journal of …, 2023 - Springer
Chronic low-grade inflammation has been identified as a major contributor in the
development of atherosclerosis. Nuclear Factor-κappa B (NF-κB) is a critical transcription …
development of atherosclerosis. Nuclear Factor-κappa B (NF-κB) is a critical transcription …
Maternal vitamin D deficiency in mice increases white adipose tissue inflammation in offspring
N Haroun, I Bennour, E Seipelt, J Astier, C Couturier… - Cells, 2022 - mdpi.com
Vitamin D is acknowledged to play an important biological and metabolic role in adipose
tissue, which is also the main storage site for this vitamin. Its anti-inflammatory effect in …
tissue, which is also the main storage site for this vitamin. Its anti-inflammatory effect in …
Dysbiosis versus diabesity: pathological signaling and promising therapeutic strategies
Highlights•Report reveals the pathological cascade in metabolic disorders.•Molecular
signalling explain how gut bacteria leads to diabesity.•Report explains the vicious circle of …
signalling explain how gut bacteria leads to diabesity.•Report explains the vicious circle of …
Costunolide alleviates atherosclerosis in high-fat diet-fed ApoE−/− mice through covalently binding to IKKβ and inhibiting NF-κB-mediated inflammation
Z Huang, W Luo, W Li, P Chen, Z Wang… - Acta Pharmacologica …, 2023 - nature.com
Costunolide (CTD) is a sesquiterpene lactone isolated from costus root and exhibits various
biological activities including anti-inflammation. Since atherosclerosis is a chronic …
biological activities including anti-inflammation. Since atherosclerosis is a chronic …
Is insulin resistance tissue-dependent and substrate-specific? The role of white adipose tissue and skeletal muscle
D Calderón-DuPont, I Torre-Villalvazo… - Biochimie, 2023 - Elsevier
Insulin resistance (IR) refers to a reduction in the ability of insulin to exert its metabolic
effects in organs such as adipose tissue (AT) and skeletal muscle (SM), leading to chronic …
effects in organs such as adipose tissue (AT) and skeletal muscle (SM), leading to chronic …
The role of interferon regulatory factors in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver
disease with many metabolic comorbidities, such as obesity, diabetes, and cardiovascular …
disease with many metabolic comorbidities, such as obesity, diabetes, and cardiovascular …